Results Support Further Exploration of Therapeutic Potential of Lomecel-B to Slow Cognitive Decline, Improve Quality of Life for Alzheimer’s Patients
Phase 2 Trial Recently Launched With First Patient Treated
https://finance.yahoo.com/news/longeveron-publishes-peer-reviewed-study-120000534.html
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.